Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
Explore the politics of medical cannabis in the UK and worldwide, including policy changes, legal developments, and debates shaping the industry.
Patients in France could soon have widespread access to medical cannabis on prescription as a three-year pilot study prepares to come to a close.
As Keir Starmer becomes the new UK Prime Minister, what impact—if any—will a Labour government have on medical cannabis policy? On Friday, 5 July, the UK woke up to a new era as Keir Starmer was elected as the first Labour Prime Minister in 14 years.
On the 1st of November 2018, legislation was introduced that was celebrated by patients, families, and advocates all over the UK. The rescheduling of cannabis meant that cannabis-based medicines could be legally prescribed for a range of conditions, marking a historic moment. But how did the law change come about? And has it lived up to the expectations of those who continue to fight for fair access to medical cannabis?
Ukraine’s President signed off on Law 3528-IX, also known as The Medical Cannabis Law, back in February. This kickstarted the legalisation of medical cannabis, designed to offer relief to those suffering from conditions like chronic pain and post-traumatic stress disorder as a result of the continued war with Russia. Here we take a look at some of the updates and amendments that have been made to accommodate for the legalisation of medical cannabis in Ukraine.
Medical cannabis was a highly politicised topic between 2015 and 2018 when the UK Home Office finally conceded that cannabis does have medicinal properties and could no longer maintain its prohibition. The evidence was undeniable, and the science was too clear to hide any longer.
In the heart of UK healthcare policy, Victoria Atkins' appointment as Health Secretary stirs controversy due to her explicit recusal from cannabis-related decisions, spotlighting the intricate dance of politics, personal interest, and the quest for equitable medical cannabis access.
Two weeks ago, Chris Philp MP revealed he is in support of the proposals made by NHS England and the Advisory Council for the Misuse of Drugs (ACMD), that would allow for the electronic prescription of schedule 2 and schedule 3 drugs.
For the second time in a matter of months, official organisations, in this case the Home Affairs Committee, have raised concerns to the government about issues in accessing cannabis-based medicines in the UK.
On Monday the 3rd of July an Early Day Motion was submitted by MP Crispin Blunt, calling on the government to allow general practitioners the right to prescribe cannabis-based medications. This motion aims to open up prescription rights to the 36,000 General Practitioners that are currently practising in the UK in the hope of making medical cannabis more accessible.
